The Holocaust and the racial hygiene doctrine that helped rationalize it still overshadow contemporary debates about using gene editing for disease prevention.

This month on Ethics Talk, Dr Sheryl Fleisch discusses strategies for delivering health services to people experiencing homelessness, including street psychiatry.

Clinicians with obligations to patients and to organizations often assess patients in law enforcement for both therapeutic and nontherapeutic purposes.

Co-creative health systems planning requires engaging patients and learning from peers.

If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.

Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"

Using social media tools in health-related research involves challenges to confidentiality, privacy, and consent.

Large precision health initiatives like the National Institutes of Health’s All of Us campaign raise important ethical questions about consent, privacy, and inclusivity. This month on Ethics Talk, we explore with Dr Katie Johansen Taber and Ysabel Duron strategies for protecting participants and ensuring that diverse communities are represented.

Empathic communication skills help motivate understanding of safety, significance of harms, impact on succeeding generations, and social consequences.

Transnational monitoring efforts should focus on safety, defining standard of care, and promoting just access to innovation.